{"gene":"PAX1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1993,"finding":"Pax1 expression in sclerotome cells is induced by and depends on an intact notochord; loss of notochord integrity in Danforth's short-tail (Sd) mice reduces Pax1 expression and produces vertebral defects similar to Pax1 null mutants, placing Pax1 downstream of notochord signaling in dorsoventral vertebral specification.","method":"Genetic epistasis (Sd × undulated double mutants), in situ hybridization for Pax1 expression, whole-mount T-antibody staining of notochord","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — reciprocal genetic interaction + expression analysis, replicated across multiple labs","pmids":["8187635"],"is_preprint":false},{"year":1994,"finding":"Pax1 protein is required for the development of vertebral bodies and intervertebral discs (ventral sclerotome derivatives) but not neural arches; complete loss of Pax1 results in failure of sclerotome cells to undergo chondrogenesis, beginning with reduced cell proliferation from day 10.5 pc.","method":"Analysis of three Pax1 mouse mutant alleles (un, unex, Uns/null) including immunohistochemistry for Pax1 protein and skeletal phenotype characterization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — multiple allelic series with graded phenotypes, replicated across labs","pmids":["8026324"],"is_preprint":false},{"year":1995,"finding":"Notochord and floor plate induce Pax1 expression in competent paraxial mesoderm (sclerotome) cells in avian embryos; limb bud mesoderm and paraxial head mesoderm lack competence to respond to notochordal signals. In vitro co-culture and in vivo grafting experiments established that Pax1 induction depends on proximity to notochord/floor plate.","method":"In vitro co-culture assays, in vivo grafting experiments, in situ hybridization in quail embryos","journal":"Anatomy and Embryology","confidence":"High","confidence_rationale":"Tier 1-2 — direct in vitro induction assay plus in vivo grafting, replicated","pmids":["7645756"],"is_preprint":false},{"year":1995,"finding":"Antisense knockdown of Pax1 in chick embryos causes somite loss, somite fusion, and shortened body axis, demonstrating a functional role for Pax1 in somitogenesis and sclerotome boundary formation.","method":"Antisense phosphorothioate oligodeoxynucleotide injection/topical application in chick embryos, histology, whole-mount in situ hybridization","journal":"Teratology","confidence":"Medium","confidence_rationale":"Tier 2 — direct loss-of-function with specific phenotypic readout, single lab","pmids":["8711620"],"is_preprint":false},{"year":1996,"finding":"Pax1 protein is expressed in thymic epithelial cells throughout development; Pax1 mutations reduce thymus size and impair T-cell maturation, specifically reducing CD4+8+ and CD4+ mature thymocyte subsets and elevating Thy-1 expression, demonstrating Pax1 is required in thymic epithelium to establish the microenvironment for T-cell maturation.","method":"Immunohistochemistry for Pax1 protein in thymus, flow cytometry of thymocyte subsets in undulated mutant mice","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — direct localization tied to functional consequence, multiple mutant alleles","pmids":["8565834"],"is_preprint":false},{"year":1996,"finding":"Endodermal expression of Pax1 and Pax9 in pharyngeal pouches is an intrinsic property of the endoderm not requiring midline structures, whereas sclerotomal Pax1 expression requires notochord induction; lateral tissues (lateral plate, intermediate mesoderm) counteract notochord signaling and inhibit Shh and Pax1/Pax9 expression.","method":"Grafting experiments of avian pharyngeal endoderm, in vitro sclerotome explant assays, in situ hybridization","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 1-2 — tissue grafting plus in vitro explant assays with multiple orthogonal approaches","pmids":["8812138"],"is_preprint":false},{"year":1998,"finding":"Pax1 acts as a transcriptional activator of the PDGFRα gene promoter in differentiated cells; the undulated point mutation (and a spina bifida-associated Gln→His mutation at position 42) reduces or abolishes this transactivation. In undifferentiated cells, mutant Pax1 unexpectedly enhances PDGFRα promoter activity (gain-of-function), correlating with altered protein-DNA interaction in band-shift assays.","method":"Luciferase reporter assay with human PDGFRα promoter in Tera-2 and U-2 OS cells, electrophoretic mobility shift assay (EMSA/band-shift)","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 — in vitro transcriptional assay plus DNA-binding assay with mutagenesis, two cell-type contexts","pmids":["9826722"],"is_preprint":false},{"year":1998,"finding":"Targeted Pax1 null allele in mice confirms that Pax1 is haploinsufficient for development of some skeletal elements (vertebral column, sternum, scapula); phenotype differs from the Uns deletion mutant, implicating additional gene(s) deleted in Uns.","method":"Gene targeting/homologous recombination in mouse ES cells, skeletal phenotype analysis of heterozygotes and homozygotes","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — defined null allele with rigorous genetic analysis","pmids":["9671740"],"is_preprint":false},{"year":1999,"finding":"Pax1 and Pax9 act synergistically and redundantly during vertebral column development; Pax1/Pax9 double mutants completely lack vertebral bodies, intervertebral discs, and proximal ribs. The primary cellular defect is reduced proliferation in ventromedial sclerotome before mesenchymal condensation, followed by increased apoptosis, preventing chondrogenesis despite normal sclerotome induction and Sox9/ColII initiation.","method":"Generation and analysis of Pax1/Pax9 double mutant mice, BrdU proliferation assays, TUNEL apoptosis assays, in situ hybridization for Sox9 and ColII","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — double KO epistasis with multiple cellular assays, strong mechanistic detail","pmids":["10556064"],"is_preprint":false},{"year":1999,"finding":"MFH1 (Foxf2) expression, like Pax1, depends on Sonic hedgehog signals from the notochord; Mfh1 and Pax1 act synergistically downstream of Shh to maintain sclerotome cell proliferation, with Mfh1/Pax1 double mutants showing extreme spina bifida, missing vertebral bodies/IVD, and reduced mitotic rate in sclerotome cells.","method":"Analysis of Mfh1/Pax1 double mutant mice, BrdU labeling, in situ hybridization, Shh signaling pathway assessment","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — double KO epistasis with proliferation assay, places Pax1 downstream of Shh","pmids":["10364424"],"is_preprint":false},{"year":2000,"finding":"Hoxa3 and Pax1 act synergistically in a transcriptional regulatory pathway required for thymic epithelial cell development; Hoxa3+/−Pax1−/− compound mutants have fewer MHC class II+ epithelial cells, reduced MHC expression, and reduced ability to promote thymocyte maturation, causing a block at the CD4−8− to CD4+8+ transition with increased apoptosis. The defect resides in radio-resistant stromal cells, not hematopoietic cells.","method":"Fetal liver adoptive transfer, flow cytometry, immunohistochemistry for MHC class II, genetic compound mutant analysis","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — adoptive transfer formally places defect in stromal compartment, multiple orthogonal methods","pmids":["10820253"],"is_preprint":false},{"year":2001,"finding":"Hoxa3 and Pax1 cooperate in a genetic pathway controlling epithelial cell proliferation and differentiation during thymus and parathyroid organogenesis; Pax1−/− single mutants show reduced Gcm2 expression (parathyroid-specific marker) and smaller parathyroids, revealing a previously unrecognized role for Pax1 in parathyroid development. Hoxa3+/−Pax1−/− compound mutants have increased apoptosis and hypoplasia of the shared thymus/parathyroid primordium.","method":"Analysis of Hoxa3;Pax1 compound mutant mice, in situ hybridization for Gcm2/Foxn1, TUNEL assay, BrdU proliferation assay","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — compound mutant epistasis with multiple molecular markers, identifies new organ-specific function","pmids":["11476574"],"is_preprint":false},{"year":2001,"finding":"Mox1 and Mox2 homeodomain proteins physically interact with Pax1 (and Pax3) through the homeodomain of Mox; Mox1 preferentially associates with Pax1, and Mox2 preferentially associates with Pax3, as shown by yeast two-hybrid and in vitro biochemical assays.","method":"Yeast two-hybrid assay, in vitro biochemical binding assay (pulldown)","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 3 — yeast two-hybrid plus in vitro pulldown, single lab","pmids":["11423130"],"is_preprint":false},{"year":2003,"finding":"Pax1 and Pax9 directly activate Bapx1 (Nkx3.2) expression in the sclerotome; Pax1/Pax9 double mutants lose Bapx1 expression in a gene-dose-dependent manner, retroviral overexpression of Pax1 in chick PSM induces Bapx1 and initiates chondrogenesis substituting for Shh, and Pax1/Pax9 transactivate the Bapx1 promoter and physically interact with Bapx1 regulatory sequences, identifying Bapx1 as a direct downstream target.","method":"Retroviral overexpression in chick PSM explants, Bapx1 promoter-luciferase reporter assay, ChIP/promoter binding assay, Pax1/Pax9 double mutant analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — overexpression gain-of-function + reporter transactivation + physical interaction with promoter, multiple methods in one study","pmids":["12490554"],"is_preprint":false},{"year":2003,"finding":"The Pax1(Un-s) deletion causes ectopic activation of Nkx2-2 in Pax1-expressing tissues (sclerotome, limb buds) by disrupting an insulator between Pax1 enhancers and the Nkx2-2 promoter; this ectopic Nkx2-2 interferes with the Pax1–Bapx1 pathway, explaining why the Uns phenotype is more severe than the defined Pax1 null.","method":"Deletion interval mapping, in situ hybridization for Nkx2-2 and Bapx1 in Pax1(Un-s) and Pax1-null embryos, comparative genomic analysis","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — comparative mutant expression analysis with mechanistic interpretation, single lab","pmids":["14504237"],"is_preprint":false},{"year":2013,"finding":"A PAX1 missense mutation (p.G166V in the paired-box domain) in otofaciocervical syndrome patients causes significantly reduced transactivation of an Nkx3-2 (Bapx1) promoter reporter, demonstrating reduced DNA-binding affinity of the mutant protein and establishing PAX1 as causative for OFCS via loss of transcriptional activator function.","method":"Dual luciferase reporter assay with Nkx3-2 promoter in HEK293T cells overexpressing WT vs. mutant Pax1, whole-exome sequencing","journal":"Human Genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro transcriptional assay with disease-associated mutant, functional validation of molecular mechanism","pmids":["23851939"],"is_preprint":false},{"year":2013,"finding":"Forced Pax1 expression in chick forelimb causes shortened skeletal elements, reduced proteoglycan accumulation, and lack of ossification/vascularization; Pax1-misexpressing chondrocytes downregulate Sox9, Nkx3.2, Ihh, Col2a1, Chm1, and Aggrecan, demonstrating that Pax1 acts as a negative regulator of chondrocyte maturation, antagonizing Sox9-driven differentiation.","method":"Retroviral overexpression of Pax1 in chick forelimb, histology, in situ hybridization, cultured chondrocyte assay","journal":"Experimental Cell Research","confidence":"Medium","confidence_rationale":"Tier 2 — overexpression gain-of-function with specific molecular readouts, single lab","pmids":["24080012"],"is_preprint":false},{"year":2019,"finding":"PAX1 inhibits phosphorylation of multiple kinases (EGF/MAPK pathway) and activates phosphatases (DUSP1, 5, 6) in cervical cancer cells upon oncogenic growth factor challenge. PAX1 physically interacts with SET1B, leading to increased histone H3K4 methylation and DNA demethylation of phosphatase-encoding genes.","method":"Co-immunoprecipitation of PAX1 with SET1B, kinase phosphorylation arrays, qRT-PCR for DUSPs, chromatin/methylation assays in cervical cancer cell lines with PAX1 overexpression","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus functional assays, single lab, moderate mechanistic detail","pmids":["31235851"],"is_preprint":false},{"year":2019,"finding":"PAX1 and PAX9 differentially regulate the upstream Aggrecan enhancer (UE) depending on the presence of SOX9; in the presence of SOX9, PAX1/9 competes with SOX9 for overlapping binding sites in the UE, reducing transactivation. Physical interaction between Pax1 and SOX9 was demonstrated by co-immunoprecipitation.","method":"Luciferase reporter assay (UE-driven), CRISPR/Cas9 deletion of UE, co-immunoprecipitation of Pax1 with SOX9, ChIP for PAX1/9 and SOX9 binding","journal":"Scientific Reports","confidence":"High","confidence_rationale":"Tier 1 — Co-IP + reporter assay + CRISPR deletion + ChIP, multiple orthogonal methods in one study","pmids":["30872687"],"is_preprint":false},{"year":2020,"finding":"Biallelic loss-of-function PAX1 mutations cause SCID due to thymus aplasia/hypoplasia; patient-derived iPSC-differentiated thymic epithelial progenitor cells show an altered transcriptional profile for genes involved in thymus and pharyngeal pouch development. Mutant PAX1 proteins have altered conformation and flexibility of the paired box domain and reduced transcriptional activity.","method":"iPSC differentiation into thymic epithelial progenitors, transcriptional activity assays of mutant PAX1, structural modeling of paired box domain conformational changes, whole-exome sequencing","journal":"Science Immunology","confidence":"High","confidence_rationale":"Tier 1-2 — iPSC functional model + transcriptional activity assay + structural analysis, multiple patients/mutations","pmids":["32111619"],"is_preprint":false},{"year":2015,"finding":"PAX1 reactivation by curcumin and resveratrol in cervical cancer cell lines is independent of promoter demethylation and is instead mediated by downregulation of UHRF1; UHRF1 silencing alone is sufficient to reactivate PAX1 expression, suggesting that non-methylation epigenetic mechanisms (histone deacetylation) regulate PAX1.","method":"qRT-PCR for PAX1 expression, bisulfite sequencing of PAX1 promoter, transient siRNA knockdown of UHRF1, treatment with 5-aza-dC and sodium butyrate in HeLa/SiHa/CaSki cells","journal":"Clinical and Experimental Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal epigenetic methods with functional knockdown, single lab","pmids":["26081871"],"is_preprint":false},{"year":2022,"finding":"PAX1 expression is epigenetically silenced in parathyroid adenomas by promoter hypermethylation (35% of cases) and reduced H3K9 acetylation; pharmacological inhibition of DNA methylation with 5'-aza-2'-deoxycytidine re-expresses PAX1 in rat parathyroid cells, establishing epigenetic deregulation as a mechanism of PAX1 silencing in parathyroid tumorigenesis.","method":"Bisulfite-specific PCR sequencing of PAX1 promoter in adenoma tissues, ChIP for H3K9ac at PAX1 promoter, 5-aza-dC treatment of rat parathyroid cells","journal":"Journal of Clinical Endocrinology and Metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + bisulfite sequencing + pharmacological re-expression, single lab","pmids":["34453169"],"is_preprint":false},{"year":2008,"finding":"Pbx1/Pbx2 control Pax1/Pax9 expression in the sclerotome as part of their governance of axial skeletal patterning; in Pbx1/Pbx2 loss-of-function mice, Pax1/Pax9 expression in the sclerotome is reduced, placing Pbx1/Pbx2 upstream of Pax1/Pax9 in the sclerotome regulatory hierarchy.","method":"Pbx1/Pbx2 compound mutant mouse analysis, in situ hybridization for Pax1/Pax9 expression, skeletal phenotype analysis","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in compound mutants with expression readout, single lab","pmids":["18691704"],"is_preprint":false},{"year":2017,"finding":"ChIP-sequencing combined with transcriptomics in Pax1/Pax9 mutant IVD cells identified Pax1/Pax9 direct targets involved in cell proliferation, cartilage development, and collagen fibrillogenesis. Pax1/Pax9 positively regulate Sox5/Sox6/Sox9 target cartilage genes and are connected to Sox5/Sox6 by a negative feedback loop; they also interact with BMP and TGF-β pathways and initiate chondrogenic gene expression during early IVD differentiation.","method":"ChIP-sequencing, RNA-seq in Pax1/Pax9 single and double mutant embryos, comparative transcriptomics","journal":"Biology Open","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq plus transcriptomics in defined mutants, moderate mechanistic resolution","pmids":["28011632"],"is_preprint":false}],"current_model":"PAX1 is a paired-box transcription factor that acts downstream of notochord-derived Sonic hedgehog signaling to drive sclerotome cell proliferation and chondrogenic differentiation (via direct transactivation of Bapx1/Nkx3.2 and competition with SOX9 at the Aggrecan enhancer), functions synergistically with PAX9 and redundantly with Mfh1 and Hoxa3 in axial skeleton and thymus/parathyroid organogenesis, physically interacts with SOX9 and SET1B to modulate chromatin state and kinase/phosphatase cascades, and is epigenetically silenced by promoter hypermethylation in multiple cancers; loss-of-function mutations cause haploinsufficient skeletal defects and biallelic null mutations cause SCID due to thymic aplasia."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing that PAX1 lies downstream of notochord signaling resolved how dorsoventral vertebral patterning is transmitted from the axial midline to surrounding mesoderm.","evidence":"Genetic epistasis between Danforth's short-tail and undulated mutants with Pax1 expression analysis in mouse embryos","pmids":["8187635"],"confidence":"High","gaps":["The notochord-derived signal molecule inducing Pax1 was not yet identified","Whether Pax1 is a direct target of notochord signals or responds indirectly was unresolved"]},{"year":1994,"claim":"Defining the Pax1-null skeletal phenotype revealed that Pax1 is specifically required for ventral sclerotome-derived structures (vertebral bodies, intervertebral discs) and acts at the proliferation stage before chondrogenesis.","evidence":"Analysis of three Pax1 allelic series (un, unex, Uns) in mouse with histology and immunohistochemistry","pmids":["8026324"],"confidence":"High","gaps":["Molecular targets mediating Pax1-driven proliferation were unknown","Relationship to other sclerotome transcription factors (e.g., Pax9) was not addressed"]},{"year":1995,"claim":"Demonstrating that only paraxial mesoderm is competent to express Pax1 in response to notochord/floor plate established tissue-specific competence as a gating mechanism for sclerotome specification.","evidence":"In vitro co-culture and in vivo grafting of avian embryonic tissues with in situ hybridization","pmids":["7645756"],"confidence":"High","gaps":["Molecular basis of competence in paraxial vs. lateral mesoderm was unknown","Whether Shh alone was sufficient to induce Pax1 had not been tested"]},{"year":1996,"claim":"Discovery that Pax1 is expressed in thymic epithelium and that its mutation impairs T-cell maturation expanded Pax1 function beyond skeleton to immune system organogenesis.","evidence":"Flow cytometry of thymocyte subsets and immunohistochemistry for Pax1 in undulated mutant mice","pmids":["8565834"],"confidence":"High","gaps":["Whether the thymic defect is cell-autonomous to epithelium was not formally demonstrated","Downstream transcriptional targets of Pax1 in thymic epithelium were unknown"]},{"year":1998,"claim":"Identifying Pax1 as a transcriptional activator of PDGFRα and showing that undulated mutations abolish transactivation provided the first direct evidence that Pax1 functions as a sequence-specific transcription factor with cell-type-dependent activity.","evidence":"Luciferase reporter assay with PDGFRα promoter and EMSA in differentiated vs. undifferentiated human cell lines","pmids":["9826722"],"confidence":"High","gaps":["Whether PDGFRα is a physiological target in sclerotome was not established","Cofactors determining cell-type-dependent activity were unknown"]},{"year":1999,"claim":"Compound Pax1/Pax9 and Pax1/Mfh1 double knockouts revealed synergistic and redundant functions of these factors downstream of Shh in sclerotome proliferation, explaining why single-gene mutations produce partial phenotypes.","evidence":"Double-mutant mouse analysis with BrdU proliferation, TUNEL apoptosis, and in situ hybridization for Sox9/ColII","pmids":["10556064","10364424"],"confidence":"High","gaps":["Direct transcriptional targets shared or distinct between Pax1 and Pax9 were undefined","Whether Mfh1 and Pax1 regulate overlapping or parallel gene sets was unclear"]},{"year":2001,"claim":"Hoxa3/Pax1 compound mutant analysis placed these factors in a shared genetic pathway controlling thymic and parathyroid epithelial proliferation and differentiation, with the defect residing in radio-resistant stroma rather than hematopoietic cells.","evidence":"Fetal liver adoptive transfer, flow cytometry, Gcm2/Foxn1 in situ hybridization in compound mutant mice","pmids":["10820253","11476574"],"confidence":"High","gaps":["Direct physical or transcriptional interaction between Hoxa3 and Pax1 was not demonstrated","Pax1 targets in thymic vs. parathyroid epithelium were not distinguished"]},{"year":2003,"claim":"Identification of Bapx1/Nkx3.2 as a direct transcriptional target of Pax1/Pax9 provided the first defined link between Pax1 DNA binding, transactivation, and initiation of chondrogenesis.","evidence":"Retroviral overexpression in chick PSM, Bapx1 promoter-luciferase reporter, ChIP, and Pax1/Pax9 double-mutant expression analysis","pmids":["12490554"],"confidence":"High","gaps":["Genome-wide Pax1 binding targets beyond Bapx1 were not identified","Whether Bapx1 alone rescues Pax1 loss was not tested"]},{"year":2013,"claim":"A disease-associated PAX1 missense mutation (p.G166V) causing otofaciocervical syndrome was shown to reduce Nkx3.2 promoter transactivation, establishing a direct genotype-to-molecular-mechanism link for a human Mendelian skeletal disorder.","evidence":"Dual luciferase reporter assay with Nkx3.2 promoter in HEK293T cells overexpressing WT vs. G166V PAX1","pmids":["23851939"],"confidence":"High","gaps":["DNA-binding affinity of the mutant was inferred but not quantitatively measured (e.g., by SPR or ITC)","Whether additional targets beyond Nkx3.2 are affected by G166V was not explored"]},{"year":2017,"claim":"Genome-wide ChIP-seq in Pax1/Pax9 mutant intervertebral disc cells identified a broad direct target network encompassing cartilage genes, Sox5/Sox6 feedback regulation, and BMP/TGF-β pathway components, defining PAX1 as a master regulator of chondrogenic gene programs.","evidence":"ChIP-sequencing and RNA-seq in Pax1/Pax9 single and double mutant mouse embryos","pmids":["28011632"],"confidence":"Medium","gaps":["Functional validation of individual ChIP-seq targets was not performed","Relative contributions of Pax1 vs. Pax9 to individual binding events were not resolved","Motif analysis did not distinguish direct from indirect binding"]},{"year":2019,"claim":"Demonstration that PAX1 physically interacts with SOX9 and competes for overlapping Aggrecan enhancer binding sites revealed a molecular mechanism by which PAX1 fine-tunes cartilage matrix gene expression rather than simply activating it.","evidence":"Co-immunoprecipitation of PAX1 with SOX9, luciferase reporter with Aggrecan upstream enhancer, CRISPR deletion of enhancer, ChIP","pmids":["30872687"],"confidence":"High","gaps":["Structural basis of the PAX1–SOX9 interaction is unknown","In vivo relevance in Pax1 mutant cartilage was not tested"]},{"year":2019,"claim":"Discovery that PAX1 interacts with the H3K4 methyltransferase SET1B and activates DUSP phosphatase genes revealed a chromatin-modifying mechanism by which PAX1 suppresses EGF/MAPK signaling, connecting its tumor-suppressive activity to epigenetic reprogramming.","evidence":"Co-immunoprecipitation of PAX1 with SET1B, kinase arrays, qRT-PCR for DUSPs, and histone/DNA methylation assays in cervical cancer cell lines","pmids":["31235851"],"confidence":"Medium","gaps":["Co-IP was not validated by reciprocal pull-down or endogenous IP","Relevance to normal developmental contexts (sclerotome, thymus) was not tested","Whether SET1B recruitment is direct or via a complex was not resolved"]},{"year":2020,"claim":"Identifying biallelic PAX1 loss-of-function as a cause of human SCID via thymic aplasia, supported by iPSC-derived thymic epithelial progenitor defects, closed a decades-long question about whether PAX1 is essential for human thymus development.","evidence":"Whole-exome sequencing of SCID patients, iPSC differentiation to thymic epithelial progenitors, transcriptional activity assays, structural modeling of paired domain","pmids":["32111619"],"confidence":"High","gaps":["Whether thymus transplant or gene correction rescues the immune defect in patients was not tested","Downstream gene network disrupted by PAX1 loss in human thymic epithelium was characterized only transcriptomically, not functionally"]},{"year":2022,"claim":"Demonstration of PAX1 promoter hypermethylation and reduced H3K9 acetylation in parathyroid adenomas, with pharmacological re-expression, implicated epigenetic silencing as a recurrent mechanism of PAX1 inactivation in endocrine tumors beyond cervical cancer.","evidence":"Bisulfite sequencing, ChIP for H3K9ac, 5-aza-dC treatment in rat parathyroid cells and human parathyroid adenoma tissues","pmids":["34453169"],"confidence":"Medium","gaps":["Functional consequence of PAX1 re-expression on parathyroid cell growth was not assessed","Whether PAX1 silencing is a driver or passenger event in parathyroid tumorigenesis is unresolved"]},{"year":null,"claim":"The structural basis of PAX1 interactions with its protein partners (SOX9, SET1B, Mox1), the genome-wide hierarchy of direct targets in thymic epithelium vs. sclerotome, and whether PAX1-based gene therapy can rescue SCID remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of PAX1 in complex with SOX9, SET1B, or DNA","Tissue-specific PAX1 cistrome comparing sclerotome, IVD, and thymic epithelium has not been generated","Functional rescue of PAX1-null SCID by thymus organoid transplant or gene correction is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,13,15,18]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[6,13,15,16,17,18,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,6,13,17,19]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,8,9,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,13,15,17,18]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,10,19]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[17]}],"complexes":[],"partners":["PAX9","SOX9","SET1B","HOXA3","MEOX1","MEOX2"],"other_free_text":[]},"mechanistic_narrative":"PAX1 is a paired-box transcription factor that drives ventral axial skeleton formation, thymus/parathyroid organogenesis, and chondrocyte differentiation downstream of notochord-derived Sonic hedgehog signaling. In the sclerotome, PAX1 promotes cell proliferation and chondrogenesis by directly transactivating Bapx1/Nkx3.2 and positively regulating cartilage matrix genes, while competing with SOX9 at the Aggrecan upstream enhancer and physically interacting with SOX9, thereby modulating the balance between chondrocyte induction and maturation [PMID:12490554, PMID:30872687, PMID:24080012]. PAX1 acts synergistically with PAX9 in vertebral body and intervertebral disc development—double-null embryos completely lack these structures due to failed sclerotome proliferation—and cooperates with Hoxa3 in thymic epithelial differentiation to support T-cell maturation [PMID:10556064, PMID:10820253]. Biallelic loss-of-function PAX1 mutations cause severe combined immunodeficiency (SCID) through thymus aplasia, and a heterozygous paired-domain missense mutation (p.G166V) causes otofaciocervical syndrome via reduced transcriptional activity [PMID:32111619, PMID:23851939]."},"prefetch_data":{"uniprot":{"accession":"P15863","full_name":"Paired box protein Pax-1","aliases":["HuP48"],"length_aa":534,"mass_kda":55.5,"function":"This protein is a transcriptional activator. It may play a role in the formation of segmented structures of the embryo. May play an important role in the normal development of the vertebral column (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P15863/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAX1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAX1","total_profiled":1310},"omim":[{"mim_id":"615560","title":"OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY; OTFCS2","url":"https://www.omim.org/entry/615560"},{"mim_id":"609067","title":"SCLERAXIS bHLH TRANSCRIPTION FACTOR; SCX","url":"https://www.omim.org/entry/609067"},{"mim_id":"608022","title":"DIAPHANOSPONDYLODYSOSTOSIS","url":"https://www.omim.org/entry/608022"},{"mim_id":"605195","title":"MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 2; MESP2","url":"https://www.omim.org/entry/605195"},{"mim_id":"601755","title":"ESS2 SPLICING FACTOR HOMOLOG; ESS2","url":"https://www.omim.org/entry/601755"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"parathyroid gland","ntpm":152.5}],"url":"https://www.proteinatlas.org/search/PAX1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P15863","domains":[{"cath_id":"1.10.10.10","chopping":"102-158","consensus_level":"high","plddt":94.8468,"start":102,"end":158},{"cath_id":"1.10.10.10","chopping":"176-222","consensus_level":"high","plddt":92.4464,"start":176,"end":222}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P15863","model_url":"https://alphafold.ebi.ac.uk/files/AF-P15863-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P15863-F1-predicted_aligned_error_v6.png","plddt_mean":54.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAX1","jax_strain_url":"https://www.jax.org/strain/search?query=PAX1"},"sequence":{"accession":"P15863","fasta_url":"https://rest.uniprot.org/uniprotkb/P15863.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P15863/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P15863"}},"corpus_meta":[{"pmid":"8026324","id":"PMC_8026324","title":"The role of Pax-1 in axial skeleton development.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8026324","citation_count":312,"is_preprint":false},{"pmid":"7649395","id":"PMC_7649395","title":"Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7649395","citation_count":232,"is_preprint":false},{"pmid":"10556064","id":"PMC_10556064","title":"Pax1 and Pax9 synergistically regulate vertebral column development.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10556064","citation_count":204,"is_preprint":false},{"pmid":"8565834","id":"PMC_8565834","title":"Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8565834","citation_count":200,"is_preprint":false},{"pmid":"8187635","id":"PMC_8187635","title":"A role for Pax-1 as a mediator of notochordal signals during the dorsoventral specification of vertebrae.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8187635","citation_count":167,"is_preprint":false},{"pmid":"9671740","id":"PMC_9671740","title":"Targeted disruption of Pax1 defines its null phenotype and proves haploinsufficiency.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9671740","citation_count":125,"is_preprint":false},{"pmid":"11476574","id":"PMC_11476574","title":"Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11476574","citation_count":113,"is_preprint":false},{"pmid":"25784220","id":"PMC_25784220","title":"A PAX1 enhancer locus is associated with susceptibility to idiopathic scoliosis in females.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25784220","citation_count":112,"is_preprint":false},{"pmid":"12490554","id":"PMC_12490554","title":"Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12490554","citation_count":108,"is_preprint":false},{"pmid":"7645756","id":"PMC_7645756","title":"Pax-1, a regulator of sclerotome development is induced by notochord and floor plate signals in avian embryos.","date":"1995","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/7645756","citation_count":102,"is_preprint":false},{"pmid":"10226012","id":"PMC_10226012","title":"Developmental expression of Pax1/9 genes in urochordate and hemichordate gills: insight into function and evolution of the pharyngeal epithelium.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10226012","citation_count":99,"is_preprint":false},{"pmid":"7875377","id":"PMC_7875377","title":"undulated phenotypes suggest a role of Pax-1 for the development of vertebral and extravertebral structures.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7875377","citation_count":98,"is_preprint":false},{"pmid":"8812138","id":"PMC_8812138","title":"Expression of avian Pax1 and Pax9 is intrinsically regulated in the pharyngeal endoderm, but depends on environmental influences in the paraxial mesoderm.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8812138","citation_count":93,"is_preprint":false},{"pmid":"10364424","id":"PMC_10364424","title":"Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10364424","citation_count":79,"is_preprint":false},{"pmid":"12774041","id":"PMC_12774041","title":"Mutations in PAX1 may be associated with Klippel-Feil syndrome.","date":"2003","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/12774041","citation_count":78,"is_preprint":false},{"pmid":"32111619","id":"PMC_32111619","title":"PAX1 is essential for development and function of the human thymus.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32111619","citation_count":75,"is_preprint":false},{"pmid":"24844223","id":"PMC_24844223","title":"PAX1 methylation as a potential biomarker for cervical cancer screening.","date":"2014","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/24844223","citation_count":66,"is_preprint":false},{"pmid":"10820253","id":"PMC_10820253","title":"Hoxa3 and pax1 transcription factors regulate the ability of fetal thymic epithelial cells to promote thymocyte development.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10820253","citation_count":61,"is_preprint":false},{"pmid":"10882524","id":"PMC_10882524","title":"Pax1/Pax9-Related genes in an agnathan vertebrate, Lampetra japonica: expression pattern of LjPax9 implies sequential evolutionary events toward the gnathostome body plan.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10882524","citation_count":55,"is_preprint":false},{"pmid":"9894676","id":"PMC_9894676","title":"Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects, and altered expression of Hoxa3 and Pax1.","date":"1998","source":"Teratology","url":"https://pubmed.ncbi.nlm.nih.gov/9894676","citation_count":54,"is_preprint":false},{"pmid":"24407576","id":"PMC_24407576","title":"High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.","date":"2014","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/24407576","citation_count":52,"is_preprint":false},{"pmid":"8863157","id":"PMC_8863157","title":"PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida.","date":"1996","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8863157","citation_count":52,"is_preprint":false},{"pmid":"28011632","id":"PMC_28011632","title":"A developmental transcriptomic analysis of Pax1 and Pax9 in embryonic intervertebral disc development.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/28011632","citation_count":51,"is_preprint":false},{"pmid":"20442585","id":"PMC_20442585","title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.","date":"2010","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/20442585","citation_count":51,"is_preprint":false},{"pmid":"7647370","id":"PMC_7647370","title":"Differential expression of the chicken Pax-1 and Pax-9 gene: in situ hybridization and immunohistochemical analysis.","date":"1995","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/7647370","citation_count":51,"is_preprint":false},{"pmid":"23851939","id":"PMC_23851939","title":"A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndrome.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23851939","citation_count":48,"is_preprint":false},{"pmid":"16207213","id":"PMC_16207213","title":"An analysis of PAX1 in the development of vertebral malformations.","date":"2005","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16207213","citation_count":48,"is_preprint":false},{"pmid":"27865370","id":"PMC_27865370","title":"Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer.","date":"2016","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27865370","citation_count":45,"is_preprint":false},{"pmid":"28657137","id":"PMC_28657137","title":"A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28657137","citation_count":45,"is_preprint":false},{"pmid":"31235851","id":"PMC_31235851","title":"Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31235851","citation_count":44,"is_preprint":false},{"pmid":"24799352","id":"PMC_24799352","title":"PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.","date":"2014","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24799352","citation_count":44,"is_preprint":false},{"pmid":"28960639","id":"PMC_28960639","title":"Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.","date":"2017","source":"Head & neck","url":"https://pubmed.ncbi.nlm.nih.gov/28960639","citation_count":43,"is_preprint":false},{"pmid":"20708786","id":"PMC_20708786","title":"Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.","date":"2010","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20708786","citation_count":39,"is_preprint":false},{"pmid":"23907469","id":"PMC_23907469","title":"DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma.","date":"2013","source":"Clinical oral investigations","url":"https://pubmed.ncbi.nlm.nih.gov/23907469","citation_count":38,"is_preprint":false},{"pmid":"18691704","id":"PMC_18691704","title":"Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18691704","citation_count":38,"is_preprint":false},{"pmid":"31629253","id":"PMC_31629253","title":"Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31629253","citation_count":38,"is_preprint":false},{"pmid":"8651506","id":"PMC_8651506","title":"Pax-1 in the development of the cervico-occipital transitional zone.","date":"1995","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/8651506","citation_count":37,"is_preprint":false},{"pmid":"28241446","id":"PMC_28241446","title":"DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.","date":"2017","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/28241446","citation_count":35,"is_preprint":false},{"pmid":"27826568","id":"PMC_27826568","title":"PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians.","date":"2016","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27826568","citation_count":35,"is_preprint":false},{"pmid":"11423130","id":"PMC_11423130","title":"Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11423130","citation_count":34,"is_preprint":false},{"pmid":"21710649","id":"PMC_21710649","title":"Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1).","date":"2011","source":"Diagnostic cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/21710649","citation_count":34,"is_preprint":false},{"pmid":"11900462","id":"PMC_11900462","title":"Cooperation of Hoxa5 and Pax1 genes during formation of the pectoral girdle.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11900462","citation_count":33,"is_preprint":false},{"pmid":"10030590","id":"PMC_10030590","title":"Expression of the paired-box genes Pax-1 and Pax-9 in limb skeleton development.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10030590","citation_count":33,"is_preprint":false},{"pmid":"12833407","id":"PMC_12833407","title":"Aberrant Pax1 and Pax9 expression in Jarcho-Levin syndrome: report of two Caucasian siblings and literature review.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12833407","citation_count":32,"is_preprint":false},{"pmid":"25973053","id":"PMC_25973053","title":"Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25973053","citation_count":32,"is_preprint":false},{"pmid":"8711620","id":"PMC_8711620","title":"Functional involvement of Pax-1 in somite development: somite dysmorphogenesis in chick embryos treated with Pax-1 paired-box antisense oligodeoxynucleotide.","date":"1995","source":"Teratology","url":"https://pubmed.ncbi.nlm.nih.gov/8711620","citation_count":30,"is_preprint":false},{"pmid":"1358810","id":"PMC_1358810","title":"Pax1, a member of the paired box-containing class of developmental control genes, is mapped to human chromosome 20p11.2 by in situ hybridization (ISH and FISH).","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1358810","citation_count":29,"is_preprint":false},{"pmid":"30636379","id":"PMC_30636379","title":"The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30636379","citation_count":28,"is_preprint":false},{"pmid":"28240513","id":"PMC_28240513","title":"Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients.","date":"2017","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/28240513","citation_count":28,"is_preprint":false},{"pmid":"26081871","id":"PMC_26081871","title":"Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1.","date":"2015","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26081871","citation_count":27,"is_preprint":false},{"pmid":"8921581","id":"PMC_8921581","title":"Chicken Pax-1 gene: structure and expression during embryonic somite development.","date":"1996","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/8921581","citation_count":27,"is_preprint":false},{"pmid":"16093716","id":"PMC_16093716","title":"The scoliosis (sco) mouse: a new allele of Pax1.","date":"2005","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16093716","citation_count":25,"is_preprint":false},{"pmid":"18395830","id":"PMC_18395830","title":"Function of Pax1 and Pax9 in the sclerotome of medaka fish.","date":"2008","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/18395830","citation_count":24,"is_preprint":false},{"pmid":"23401059","id":"PMC_23401059","title":"Characterization of pax1, pax9, and uncx sclerotomal genes during Xenopus laevis embryogenesis.","date":"2013","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23401059","citation_count":24,"is_preprint":false},{"pmid":"9786420","id":"PMC_9786420","title":"Inhibitory action of BMPs on Pax1 expression and on shoulder girdle formation during limb development.","date":"1998","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9786420","citation_count":23,"is_preprint":false},{"pmid":"29681087","id":"PMC_29681087","title":"Autosomal recessive otofaciocervical syndrome type 2 with novel homozygous small insertion in PAX1 gene.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/29681087","citation_count":23,"is_preprint":false},{"pmid":"26234429","id":"PMC_26234429","title":"PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.","date":"2015","source":"Cancer epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/26234429","citation_count":23,"is_preprint":false},{"pmid":"34453169","id":"PMC_34453169","title":"Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.","date":"2022","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34453169","citation_count":21,"is_preprint":false},{"pmid":"9826722","id":"PMC_9826722","title":"Altered regulation of platelet-derived growth factor receptor-alpha gene-transcription in vitro by spina bifida-associated mutant Pax1 proteins.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9826722","citation_count":21,"is_preprint":false},{"pmid":"30872687","id":"PMC_30872687","title":"Differential transactivation of the upstream aggrecan enhancer regulated by PAX1/9 depends on SOX9-driven transactivation.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30872687","citation_count":21,"is_preprint":false},{"pmid":"24080012","id":"PMC_24080012","title":"Pax1 acts as a negative regulator of chondrocyte maturation.","date":"2013","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24080012","citation_count":21,"is_preprint":false},{"pmid":"17182894","id":"PMC_17182894","title":"Comparison of Pax1/9 locus reveals 500-Myr-old syntenic block and evolutionary conserved noncoding regions.","date":"2006","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/17182894","citation_count":20,"is_preprint":false},{"pmid":"36393845","id":"PMC_36393845","title":"An overview of PAX1: Expression, function and regulation in development and diseases.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36393845","citation_count":20,"is_preprint":false},{"pmid":"27789946","id":"PMC_27789946","title":"Real-time colorimetric detection of DNA methylation of the PAX1 gene in cervical scrapings for cervical cancer screening with thiol-labeled PCR primers and gold nanoparticles.","date":"2016","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/27789946","citation_count":19,"is_preprint":false},{"pmid":"26320460","id":"PMC_26320460","title":"Value of PAX1 Methylation Analysis by MS-HRM in the Triage of Atypical Squamous Cells of Undetermined Significance.","date":"2015","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/26320460","citation_count":18,"is_preprint":false},{"pmid":"28472814","id":"PMC_28472814","title":"PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.","date":"2017","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/28472814","citation_count":18,"is_preprint":false},{"pmid":"14504237","id":"PMC_14504237","title":"Undulated short-tail deletion mutation in the mouse ablates Pax1 and leads to ectopic activation of neighboring Nkx2-2 in domains that normally express Pax1.","date":"2003","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14504237","citation_count":17,"is_preprint":false},{"pmid":"29095406","id":"PMC_29095406","title":"Genetic Variant of PAX1 Gene Is Functionally Associated With Adolescent Idiopathic Scoliosis in the Chinese Population.","date":"2018","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/29095406","citation_count":16,"is_preprint":false},{"pmid":"17764081","id":"PMC_17764081","title":"Diaphanospondylodysostosis: six new cases and exclusion of the candidate genes, PAX1 and MEOX1.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17764081","citation_count":16,"is_preprint":false},{"pmid":"32428271","id":"PMC_32428271","title":"Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma.","date":"2020","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32428271","citation_count":15,"is_preprint":false},{"pmid":"34036681","id":"PMC_34036681","title":"The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.","date":"2021","source":"The journal of obstetrics and gynaecology research","url":"https://pubmed.ncbi.nlm.nih.gov/34036681","citation_count":15,"is_preprint":false},{"pmid":"27034424","id":"PMC_27034424","title":"Reiterative expression of pax1 directs pharyngeal pouch segmentation in medaka.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27034424","citation_count":14,"is_preprint":false},{"pmid":"32616628","id":"PMC_32616628","title":"Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.","date":"2020","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/32616628","citation_count":14,"is_preprint":false},{"pmid":"37681081","id":"PMC_37681081","title":"Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening.","date":"2023","source":"CytoJournal","url":"https://pubmed.ncbi.nlm.nih.gov/37681081","citation_count":14,"is_preprint":false},{"pmid":"18594453","id":"PMC_18594453","title":"Association between the development of the body axis and the craniofacial skeleton studied by immunohistochemical analyses using collagen II, Pax9, Pax1, and Noggin antibodies.","date":"2008","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/18594453","citation_count":14,"is_preprint":false},{"pmid":"30572100","id":"PMC_30572100","title":"Genetic polymorphisms of PAX1 are functionally associated with different PUMC types of adolescent idiopathic scoliosis in a northern Chinese Han population.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30572100","citation_count":14,"is_preprint":false},{"pmid":"34335930","id":"PMC_34335930","title":"Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34335930","citation_count":13,"is_preprint":false},{"pmid":"35402629","id":"PMC_35402629","title":"Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case-Control Study.","date":"2022","source":"Open forum infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35402629","citation_count":13,"is_preprint":false},{"pmid":"24568514","id":"PMC_24568514","title":"PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.","date":"2014","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/24568514","citation_count":13,"is_preprint":false},{"pmid":"39327707","id":"PMC_39327707","title":"PAX1/SOX1 DNA Methylation Versus Cytology and HPV16/18 Genotyping for the Triage of High-Risk HPV-Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples.","date":"2024","source":"BJOG : an international journal of obstetrics and gynaecology","url":"https://pubmed.ncbi.nlm.nih.gov/39327707","citation_count":12,"is_preprint":false},{"pmid":"17430601","id":"PMC_17430601","title":"pax1-1 partially suppresses gain-of-function mutations in Arabidopsis AXR3/IAA17.","date":"2007","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/17430601","citation_count":12,"is_preprint":false},{"pmid":"23377878","id":"PMC_23377878","title":"Pax1(EGFP): new wildtype and mutant EGFP mouse lines for molecular and fate mapping studies.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23377878","citation_count":11,"is_preprint":false},{"pmid":"12241558","id":"PMC_12241558","title":"Stage-specific changes in fetal thymocyte proliferation during the CD4-8- to CD4+8+ transition in wild type, Rag1-/-, and Hoxa3,Pax1 mutant mice.","date":"2002","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12241558","citation_count":11,"is_preprint":false},{"pmid":"32514824","id":"PMC_32514824","title":"The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.","date":"2020","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/32514824","citation_count":11,"is_preprint":false},{"pmid":"27705080","id":"PMC_27705080","title":"Generation of Pax1/PAX1-Specific Monoclonal Antibodies.","date":"2016","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/27705080","citation_count":10,"is_preprint":false},{"pmid":"38727013","id":"PMC_38727013","title":"Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.","date":"2024","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/38727013","citation_count":10,"is_preprint":false},{"pmid":"25504927","id":"PMC_25504927","title":"The role of the Pax1/9 gene in the early development of amphioxus pharyngeal gill slits.","date":"2015","source":"Journal of experimental zoology. Part B, Molecular and developmental evolution","url":"https://pubmed.ncbi.nlm.nih.gov/25504927","citation_count":10,"is_preprint":false},{"pmid":"10899593","id":"PMC_10899593","title":"Evolutionary conservation of gene structures of the Pax1/9 gene family.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10899593","citation_count":10,"is_preprint":false},{"pmid":"39152491","id":"PMC_39152491","title":"Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China.","date":"2024","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/39152491","citation_count":10,"is_preprint":false},{"pmid":"34938962","id":"PMC_34938962","title":"The effects of Tbx15 and Pax1 on facial and other physical morphology in mice.","date":"2021","source":"FASEB bioAdvances","url":"https://pubmed.ncbi.nlm.nih.gov/34938962","citation_count":8,"is_preprint":false},{"pmid":"37020401","id":"PMC_37020401","title":"Evaluation of PAX1/ST6GALNAC5 methylation as a triage test for cervical intraepithelial neoplasia and cervical cancer.","date":"2023","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/37020401","citation_count":8,"is_preprint":false},{"pmid":"36799003","id":"PMC_36799003","title":"PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.","date":"2023","source":"Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology","url":"https://pubmed.ncbi.nlm.nih.gov/36799003","citation_count":8,"is_preprint":false},{"pmid":"39304838","id":"PMC_39304838","title":"Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.","date":"2024","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39304838","citation_count":7,"is_preprint":false},{"pmid":"39528979","id":"PMC_39528979","title":"Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).","date":"2024","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39528979","citation_count":7,"is_preprint":false},{"pmid":"39726021","id":"PMC_39726021","title":"Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women.","date":"2024","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/39726021","citation_count":7,"is_preprint":false},{"pmid":"26642709","id":"PMC_26642709","title":"PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis.","date":"2015","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/26642709","citation_count":7,"is_preprint":false},{"pmid":"37689091","id":"PMC_37689091","title":"Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients.","date":"2023","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/37689091","citation_count":6,"is_preprint":false},{"pmid":"31589957","id":"PMC_31589957","title":"Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31589957","citation_count":6,"is_preprint":false},{"pmid":"35595062","id":"PMC_35595062","title":"Dysmorphism and immunodeficiency - One of the differential diagnoses is PAX1 related otofaciocervical syndrome type 2.","date":"2022","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35595062","citation_count":6,"is_preprint":false},{"pmid":"7981852","id":"PMC_7981852","title":"The undulated mouse and the development of the vertebral column. Is there a human PAX-1 homologue?","date":"1994","source":"Clinical dysmorphology","url":"https://pubmed.ncbi.nlm.nih.gov/7981852","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53418,"output_tokens":6103,"usd":0.125899},"stage2":{"model":"claude-opus-4-6","input_tokens":9728,"output_tokens":3793,"usd":0.215198},"total_usd":0.341097,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"Pax1 expression in sclerotome cells is induced by and depends on an intact notochord; loss of notochord integrity in Danforth's short-tail (Sd) mice reduces Pax1 expression and produces vertebral defects similar to Pax1 null mutants, placing Pax1 downstream of notochord signaling in dorsoventral vertebral specification.\",\n      \"method\": \"Genetic epistasis (Sd × undulated double mutants), in situ hybridization for Pax1 expression, whole-mount T-antibody staining of notochord\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic interaction + expression analysis, replicated across multiple labs\",\n      \"pmids\": [\"8187635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Pax1 protein is required for the development of vertebral bodies and intervertebral discs (ventral sclerotome derivatives) but not neural arches; complete loss of Pax1 results in failure of sclerotome cells to undergo chondrogenesis, beginning with reduced cell proliferation from day 10.5 pc.\",\n      \"method\": \"Analysis of three Pax1 mouse mutant alleles (un, unex, Uns/null) including immunohistochemistry for Pax1 protein and skeletal phenotype characterization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple allelic series with graded phenotypes, replicated across labs\",\n      \"pmids\": [\"8026324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Notochord and floor plate induce Pax1 expression in competent paraxial mesoderm (sclerotome) cells in avian embryos; limb bud mesoderm and paraxial head mesoderm lack competence to respond to notochordal signals. In vitro co-culture and in vivo grafting experiments established that Pax1 induction depends on proximity to notochord/floor plate.\",\n      \"method\": \"In vitro co-culture assays, in vivo grafting experiments, in situ hybridization in quail embryos\",\n      \"journal\": \"Anatomy and Embryology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct in vitro induction assay plus in vivo grafting, replicated\",\n      \"pmids\": [\"7645756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Antisense knockdown of Pax1 in chick embryos causes somite loss, somite fusion, and shortened body axis, demonstrating a functional role for Pax1 in somitogenesis and sclerotome boundary formation.\",\n      \"method\": \"Antisense phosphorothioate oligodeoxynucleotide injection/topical application in chick embryos, histology, whole-mount in situ hybridization\",\n      \"journal\": \"Teratology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct loss-of-function with specific phenotypic readout, single lab\",\n      \"pmids\": [\"8711620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Pax1 protein is expressed in thymic epithelial cells throughout development; Pax1 mutations reduce thymus size and impair T-cell maturation, specifically reducing CD4+8+ and CD4+ mature thymocyte subsets and elevating Thy-1 expression, demonstrating Pax1 is required in thymic epithelium to establish the microenvironment for T-cell maturation.\",\n      \"method\": \"Immunohistochemistry for Pax1 protein in thymus, flow cytometry of thymocyte subsets in undulated mutant mice\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization tied to functional consequence, multiple mutant alleles\",\n      \"pmids\": [\"8565834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Endodermal expression of Pax1 and Pax9 in pharyngeal pouches is an intrinsic property of the endoderm not requiring midline structures, whereas sclerotomal Pax1 expression requires notochord induction; lateral tissues (lateral plate, intermediate mesoderm) counteract notochord signaling and inhibit Shh and Pax1/Pax9 expression.\",\n      \"method\": \"Grafting experiments of avian pharyngeal endoderm, in vitro sclerotome explant assays, in situ hybridization\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — tissue grafting plus in vitro explant assays with multiple orthogonal approaches\",\n      \"pmids\": [\"8812138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Pax1 acts as a transcriptional activator of the PDGFRα gene promoter in differentiated cells; the undulated point mutation (and a spina bifida-associated Gln→His mutation at position 42) reduces or abolishes this transactivation. In undifferentiated cells, mutant Pax1 unexpectedly enhances PDGFRα promoter activity (gain-of-function), correlating with altered protein-DNA interaction in band-shift assays.\",\n      \"method\": \"Luciferase reporter assay with human PDGFRα promoter in Tera-2 and U-2 OS cells, electrophoretic mobility shift assay (EMSA/band-shift)\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transcriptional assay plus DNA-binding assay with mutagenesis, two cell-type contexts\",\n      \"pmids\": [\"9826722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Targeted Pax1 null allele in mice confirms that Pax1 is haploinsufficient for development of some skeletal elements (vertebral column, sternum, scapula); phenotype differs from the Uns deletion mutant, implicating additional gene(s) deleted in Uns.\",\n      \"method\": \"Gene targeting/homologous recombination in mouse ES cells, skeletal phenotype analysis of heterozygotes and homozygotes\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined null allele with rigorous genetic analysis\",\n      \"pmids\": [\"9671740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax1 and Pax9 act synergistically and redundantly during vertebral column development; Pax1/Pax9 double mutants completely lack vertebral bodies, intervertebral discs, and proximal ribs. The primary cellular defect is reduced proliferation in ventromedial sclerotome before mesenchymal condensation, followed by increased apoptosis, preventing chondrogenesis despite normal sclerotome induction and Sox9/ColII initiation.\",\n      \"method\": \"Generation and analysis of Pax1/Pax9 double mutant mice, BrdU proliferation assays, TUNEL apoptosis assays, in situ hybridization for Sox9 and ColII\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double KO epistasis with multiple cellular assays, strong mechanistic detail\",\n      \"pmids\": [\"10556064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MFH1 (Foxf2) expression, like Pax1, depends on Sonic hedgehog signals from the notochord; Mfh1 and Pax1 act synergistically downstream of Shh to maintain sclerotome cell proliferation, with Mfh1/Pax1 double mutants showing extreme spina bifida, missing vertebral bodies/IVD, and reduced mitotic rate in sclerotome cells.\",\n      \"method\": \"Analysis of Mfh1/Pax1 double mutant mice, BrdU labeling, in situ hybridization, Shh signaling pathway assessment\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double KO epistasis with proliferation assay, places Pax1 downstream of Shh\",\n      \"pmids\": [\"10364424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hoxa3 and Pax1 act synergistically in a transcriptional regulatory pathway required for thymic epithelial cell development; Hoxa3+/−Pax1−/− compound mutants have fewer MHC class II+ epithelial cells, reduced MHC expression, and reduced ability to promote thymocyte maturation, causing a block at the CD4−8− to CD4+8+ transition with increased apoptosis. The defect resides in radio-resistant stromal cells, not hematopoietic cells.\",\n      \"method\": \"Fetal liver adoptive transfer, flow cytometry, immunohistochemistry for MHC class II, genetic compound mutant analysis\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — adoptive transfer formally places defect in stromal compartment, multiple orthogonal methods\",\n      \"pmids\": [\"10820253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hoxa3 and Pax1 cooperate in a genetic pathway controlling epithelial cell proliferation and differentiation during thymus and parathyroid organogenesis; Pax1−/− single mutants show reduced Gcm2 expression (parathyroid-specific marker) and smaller parathyroids, revealing a previously unrecognized role for Pax1 in parathyroid development. Hoxa3+/−Pax1−/− compound mutants have increased apoptosis and hypoplasia of the shared thymus/parathyroid primordium.\",\n      \"method\": \"Analysis of Hoxa3;Pax1 compound mutant mice, in situ hybridization for Gcm2/Foxn1, TUNEL assay, BrdU proliferation assay\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — compound mutant epistasis with multiple molecular markers, identifies new organ-specific function\",\n      \"pmids\": [\"11476574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mox1 and Mox2 homeodomain proteins physically interact with Pax1 (and Pax3) through the homeodomain of Mox; Mox1 preferentially associates with Pax1, and Mox2 preferentially associates with Pax3, as shown by yeast two-hybrid and in vitro biochemical assays.\",\n      \"method\": \"Yeast two-hybrid assay, in vitro biochemical binding assay (pulldown)\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid plus in vitro pulldown, single lab\",\n      \"pmids\": [\"11423130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pax1 and Pax9 directly activate Bapx1 (Nkx3.2) expression in the sclerotome; Pax1/Pax9 double mutants lose Bapx1 expression in a gene-dose-dependent manner, retroviral overexpression of Pax1 in chick PSM induces Bapx1 and initiates chondrogenesis substituting for Shh, and Pax1/Pax9 transactivate the Bapx1 promoter and physically interact with Bapx1 regulatory sequences, identifying Bapx1 as a direct downstream target.\",\n      \"method\": \"Retroviral overexpression in chick PSM explants, Bapx1 promoter-luciferase reporter assay, ChIP/promoter binding assay, Pax1/Pax9 double mutant analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — overexpression gain-of-function + reporter transactivation + physical interaction with promoter, multiple methods in one study\",\n      \"pmids\": [\"12490554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Pax1(Un-s) deletion causes ectopic activation of Nkx2-2 in Pax1-expressing tissues (sclerotome, limb buds) by disrupting an insulator between Pax1 enhancers and the Nkx2-2 promoter; this ectopic Nkx2-2 interferes with the Pax1–Bapx1 pathway, explaining why the Uns phenotype is more severe than the defined Pax1 null.\",\n      \"method\": \"Deletion interval mapping, in situ hybridization for Nkx2-2 and Bapx1 in Pax1(Un-s) and Pax1-null embryos, comparative genomic analysis\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — comparative mutant expression analysis with mechanistic interpretation, single lab\",\n      \"pmids\": [\"14504237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A PAX1 missense mutation (p.G166V in the paired-box domain) in otofaciocervical syndrome patients causes significantly reduced transactivation of an Nkx3-2 (Bapx1) promoter reporter, demonstrating reduced DNA-binding affinity of the mutant protein and establishing PAX1 as causative for OFCS via loss of transcriptional activator function.\",\n      \"method\": \"Dual luciferase reporter assay with Nkx3-2 promoter in HEK293T cells overexpressing WT vs. mutant Pax1, whole-exome sequencing\",\n      \"journal\": \"Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transcriptional assay with disease-associated mutant, functional validation of molecular mechanism\",\n      \"pmids\": [\"23851939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Forced Pax1 expression in chick forelimb causes shortened skeletal elements, reduced proteoglycan accumulation, and lack of ossification/vascularization; Pax1-misexpressing chondrocytes downregulate Sox9, Nkx3.2, Ihh, Col2a1, Chm1, and Aggrecan, demonstrating that Pax1 acts as a negative regulator of chondrocyte maturation, antagonizing Sox9-driven differentiation.\",\n      \"method\": \"Retroviral overexpression of Pax1 in chick forelimb, histology, in situ hybridization, cultured chondrocyte assay\",\n      \"journal\": \"Experimental Cell Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — overexpression gain-of-function with specific molecular readouts, single lab\",\n      \"pmids\": [\"24080012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAX1 inhibits phosphorylation of multiple kinases (EGF/MAPK pathway) and activates phosphatases (DUSP1, 5, 6) in cervical cancer cells upon oncogenic growth factor challenge. PAX1 physically interacts with SET1B, leading to increased histone H3K4 methylation and DNA demethylation of phosphatase-encoding genes.\",\n      \"method\": \"Co-immunoprecipitation of PAX1 with SET1B, kinase phosphorylation arrays, qRT-PCR for DUSPs, chromatin/methylation assays in cervical cancer cell lines with PAX1 overexpression\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus functional assays, single lab, moderate mechanistic detail\",\n      \"pmids\": [\"31235851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAX1 and PAX9 differentially regulate the upstream Aggrecan enhancer (UE) depending on the presence of SOX9; in the presence of SOX9, PAX1/9 competes with SOX9 for overlapping binding sites in the UE, reducing transactivation. Physical interaction between Pax1 and SOX9 was demonstrated by co-immunoprecipitation.\",\n      \"method\": \"Luciferase reporter assay (UE-driven), CRISPR/Cas9 deletion of UE, co-immunoprecipitation of Pax1 with SOX9, ChIP for PAX1/9 and SOX9 binding\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — Co-IP + reporter assay + CRISPR deletion + ChIP, multiple orthogonal methods in one study\",\n      \"pmids\": [\"30872687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Biallelic loss-of-function PAX1 mutations cause SCID due to thymus aplasia/hypoplasia; patient-derived iPSC-differentiated thymic epithelial progenitor cells show an altered transcriptional profile for genes involved in thymus and pharyngeal pouch development. Mutant PAX1 proteins have altered conformation and flexibility of the paired box domain and reduced transcriptional activity.\",\n      \"method\": \"iPSC differentiation into thymic epithelial progenitors, transcriptional activity assays of mutant PAX1, structural modeling of paired box domain conformational changes, whole-exome sequencing\",\n      \"journal\": \"Science Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — iPSC functional model + transcriptional activity assay + structural analysis, multiple patients/mutations\",\n      \"pmids\": [\"32111619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAX1 reactivation by curcumin and resveratrol in cervical cancer cell lines is independent of promoter demethylation and is instead mediated by downregulation of UHRF1; UHRF1 silencing alone is sufficient to reactivate PAX1 expression, suggesting that non-methylation epigenetic mechanisms (histone deacetylation) regulate PAX1.\",\n      \"method\": \"qRT-PCR for PAX1 expression, bisulfite sequencing of PAX1 promoter, transient siRNA knockdown of UHRF1, treatment with 5-aza-dC and sodium butyrate in HeLa/SiHa/CaSki cells\",\n      \"journal\": \"Clinical and Experimental Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal epigenetic methods with functional knockdown, single lab\",\n      \"pmids\": [\"26081871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PAX1 expression is epigenetically silenced in parathyroid adenomas by promoter hypermethylation (35% of cases) and reduced H3K9 acetylation; pharmacological inhibition of DNA methylation with 5'-aza-2'-deoxycytidine re-expresses PAX1 in rat parathyroid cells, establishing epigenetic deregulation as a mechanism of PAX1 silencing in parathyroid tumorigenesis.\",\n      \"method\": \"Bisulfite-specific PCR sequencing of PAX1 promoter in adenoma tissues, ChIP for H3K9ac at PAX1 promoter, 5-aza-dC treatment of rat parathyroid cells\",\n      \"journal\": \"Journal of Clinical Endocrinology and Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + bisulfite sequencing + pharmacological re-expression, single lab\",\n      \"pmids\": [\"34453169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pbx1/Pbx2 control Pax1/Pax9 expression in the sclerotome as part of their governance of axial skeletal patterning; in Pbx1/Pbx2 loss-of-function mice, Pax1/Pax9 expression in the sclerotome is reduced, placing Pbx1/Pbx2 upstream of Pax1/Pax9 in the sclerotome regulatory hierarchy.\",\n      \"method\": \"Pbx1/Pbx2 compound mutant mouse analysis, in situ hybridization for Pax1/Pax9 expression, skeletal phenotype analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in compound mutants with expression readout, single lab\",\n      \"pmids\": [\"18691704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ChIP-sequencing combined with transcriptomics in Pax1/Pax9 mutant IVD cells identified Pax1/Pax9 direct targets involved in cell proliferation, cartilage development, and collagen fibrillogenesis. Pax1/Pax9 positively regulate Sox5/Sox6/Sox9 target cartilage genes and are connected to Sox5/Sox6 by a negative feedback loop; they also interact with BMP and TGF-β pathways and initiate chondrogenic gene expression during early IVD differentiation.\",\n      \"method\": \"ChIP-sequencing, RNA-seq in Pax1/Pax9 single and double mutant embryos, comparative transcriptomics\",\n      \"journal\": \"Biology Open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus transcriptomics in defined mutants, moderate mechanistic resolution\",\n      \"pmids\": [\"28011632\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAX1 is a paired-box transcription factor that acts downstream of notochord-derived Sonic hedgehog signaling to drive sclerotome cell proliferation and chondrogenic differentiation (via direct transactivation of Bapx1/Nkx3.2 and competition with SOX9 at the Aggrecan enhancer), functions synergistically with PAX9 and redundantly with Mfh1 and Hoxa3 in axial skeleton and thymus/parathyroid organogenesis, physically interacts with SOX9 and SET1B to modulate chromatin state and kinase/phosphatase cascades, and is epigenetically silenced by promoter hypermethylation in multiple cancers; loss-of-function mutations cause haploinsufficient skeletal defects and biallelic null mutations cause SCID due to thymic aplasia.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PAX1 is a paired-box transcription factor that drives ventral axial skeleton formation, thymus/parathyroid organogenesis, and chondrocyte differentiation downstream of notochord-derived Sonic hedgehog signaling. In the sclerotome, PAX1 promotes cell proliferation and chondrogenesis by directly transactivating Bapx1/Nkx3.2 and positively regulating cartilage matrix genes, while competing with SOX9 at the Aggrecan upstream enhancer and physically interacting with SOX9, thereby modulating the balance between chondrocyte induction and maturation [PMID:12490554, PMID:30872687, PMID:24080012]. PAX1 acts synergistically with PAX9 in vertebral body and intervertebral disc development—double-null embryos completely lack these structures due to failed sclerotome proliferation—and cooperates with Hoxa3 in thymic epithelial differentiation to support T-cell maturation [PMID:10556064, PMID:10820253]. Biallelic loss-of-function PAX1 mutations cause severe combined immunodeficiency (SCID) through thymus aplasia, and a heterozygous paired-domain missense mutation (p.G166V) causes otofaciocervical syndrome via reduced transcriptional activity [PMID:32111619, PMID:23851939].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing that PAX1 lies downstream of notochord signaling resolved how dorsoventral vertebral patterning is transmitted from the axial midline to surrounding mesoderm.\",\n      \"evidence\": \"Genetic epistasis between Danforth's short-tail and undulated mutants with Pax1 expression analysis in mouse embryos\",\n      \"pmids\": [\"8187635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The notochord-derived signal molecule inducing Pax1 was not yet identified\",\n        \"Whether Pax1 is a direct target of notochord signals or responds indirectly was unresolved\"\n      ]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defining the Pax1-null skeletal phenotype revealed that Pax1 is specifically required for ventral sclerotome-derived structures (vertebral bodies, intervertebral discs) and acts at the proliferation stage before chondrogenesis.\",\n      \"evidence\": \"Analysis of three Pax1 allelic series (un, unex, Uns) in mouse with histology and immunohistochemistry\",\n      \"pmids\": [\"8026324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular targets mediating Pax1-driven proliferation were unknown\",\n        \"Relationship to other sclerotome transcription factors (e.g., Pax9) was not addressed\"\n      ]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that only paraxial mesoderm is competent to express Pax1 in response to notochord/floor plate established tissue-specific competence as a gating mechanism for sclerotome specification.\",\n      \"evidence\": \"In vitro co-culture and in vivo grafting of avian embryonic tissues with in situ hybridization\",\n      \"pmids\": [\"7645756\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis of competence in paraxial vs. lateral mesoderm was unknown\",\n        \"Whether Shh alone was sufficient to induce Pax1 had not been tested\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Discovery that Pax1 is expressed in thymic epithelium and that its mutation impairs T-cell maturation expanded Pax1 function beyond skeleton to immune system organogenesis.\",\n      \"evidence\": \"Flow cytometry of thymocyte subsets and immunohistochemistry for Pax1 in undulated mutant mice\",\n      \"pmids\": [\"8565834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the thymic defect is cell-autonomous to epithelium was not formally demonstrated\",\n        \"Downstream transcriptional targets of Pax1 in thymic epithelium were unknown\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying Pax1 as a transcriptional activator of PDGFRα and showing that undulated mutations abolish transactivation provided the first direct evidence that Pax1 functions as a sequence-specific transcription factor with cell-type-dependent activity.\",\n      \"evidence\": \"Luciferase reporter assay with PDGFRα promoter and EMSA in differentiated vs. undifferentiated human cell lines\",\n      \"pmids\": [\"9826722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether PDGFRα is a physiological target in sclerotome was not established\",\n        \"Cofactors determining cell-type-dependent activity were unknown\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Compound Pax1/Pax9 and Pax1/Mfh1 double knockouts revealed synergistic and redundant functions of these factors downstream of Shh in sclerotome proliferation, explaining why single-gene mutations produce partial phenotypes.\",\n      \"evidence\": \"Double-mutant mouse analysis with BrdU proliferation, TUNEL apoptosis, and in situ hybridization for Sox9/ColII\",\n      \"pmids\": [\"10556064\", \"10364424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct transcriptional targets shared or distinct between Pax1 and Pax9 were undefined\",\n        \"Whether Mfh1 and Pax1 regulate overlapping or parallel gene sets was unclear\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Hoxa3/Pax1 compound mutant analysis placed these factors in a shared genetic pathway controlling thymic and parathyroid epithelial proliferation and differentiation, with the defect residing in radio-resistant stroma rather than hematopoietic cells.\",\n      \"evidence\": \"Fetal liver adoptive transfer, flow cytometry, Gcm2/Foxn1 in situ hybridization in compound mutant mice\",\n      \"pmids\": [\"10820253\", \"11476574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct physical or transcriptional interaction between Hoxa3 and Pax1 was not demonstrated\",\n        \"Pax1 targets in thymic vs. parathyroid epithelium were not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of Bapx1/Nkx3.2 as a direct transcriptional target of Pax1/Pax9 provided the first defined link between Pax1 DNA binding, transactivation, and initiation of chondrogenesis.\",\n      \"evidence\": \"Retroviral overexpression in chick PSM, Bapx1 promoter-luciferase reporter, ChIP, and Pax1/Pax9 double-mutant expression analysis\",\n      \"pmids\": [\"12490554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Genome-wide Pax1 binding targets beyond Bapx1 were not identified\",\n        \"Whether Bapx1 alone rescues Pax1 loss was not tested\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A disease-associated PAX1 missense mutation (p.G166V) causing otofaciocervical syndrome was shown to reduce Nkx3.2 promoter transactivation, establishing a direct genotype-to-molecular-mechanism link for a human Mendelian skeletal disorder.\",\n      \"evidence\": \"Dual luciferase reporter assay with Nkx3.2 promoter in HEK293T cells overexpressing WT vs. G166V PAX1\",\n      \"pmids\": [\"23851939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"DNA-binding affinity of the mutant was inferred but not quantitatively measured (e.g., by SPR or ITC)\",\n        \"Whether additional targets beyond Nkx3.2 are affected by G166V was not explored\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Genome-wide ChIP-seq in Pax1/Pax9 mutant intervertebral disc cells identified a broad direct target network encompassing cartilage genes, Sox5/Sox6 feedback regulation, and BMP/TGF-β pathway components, defining PAX1 as a master regulator of chondrogenic gene programs.\",\n      \"evidence\": \"ChIP-sequencing and RNA-seq in Pax1/Pax9 single and double mutant mouse embryos\",\n      \"pmids\": [\"28011632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional validation of individual ChIP-seq targets was not performed\",\n        \"Relative contributions of Pax1 vs. Pax9 to individual binding events were not resolved\",\n        \"Motif analysis did not distinguish direct from indirect binding\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that PAX1 physically interacts with SOX9 and competes for overlapping Aggrecan enhancer binding sites revealed a molecular mechanism by which PAX1 fine-tunes cartilage matrix gene expression rather than simply activating it.\",\n      \"evidence\": \"Co-immunoprecipitation of PAX1 with SOX9, luciferase reporter with Aggrecan upstream enhancer, CRISPR deletion of enhancer, ChIP\",\n      \"pmids\": [\"30872687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the PAX1–SOX9 interaction is unknown\",\n        \"In vivo relevance in Pax1 mutant cartilage was not tested\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that PAX1 interacts with the H3K4 methyltransferase SET1B and activates DUSP phosphatase genes revealed a chromatin-modifying mechanism by which PAX1 suppresses EGF/MAPK signaling, connecting its tumor-suppressive activity to epigenetic reprogramming.\",\n      \"evidence\": \"Co-immunoprecipitation of PAX1 with SET1B, kinase arrays, qRT-PCR for DUSPs, and histone/DNA methylation assays in cervical cancer cell lines\",\n      \"pmids\": [\"31235851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Co-IP was not validated by reciprocal pull-down or endogenous IP\",\n        \"Relevance to normal developmental contexts (sclerotome, thymus) was not tested\",\n        \"Whether SET1B recruitment is direct or via a complex was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying biallelic PAX1 loss-of-function as a cause of human SCID via thymic aplasia, supported by iPSC-derived thymic epithelial progenitor defects, closed a decades-long question about whether PAX1 is essential for human thymus development.\",\n      \"evidence\": \"Whole-exome sequencing of SCID patients, iPSC differentiation to thymic epithelial progenitors, transcriptional activity assays, structural modeling of paired domain\",\n      \"pmids\": [\"32111619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether thymus transplant or gene correction rescues the immune defect in patients was not tested\",\n        \"Downstream gene network disrupted by PAX1 loss in human thymic epithelium was characterized only transcriptomically, not functionally\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstration of PAX1 promoter hypermethylation and reduced H3K9 acetylation in parathyroid adenomas, with pharmacological re-expression, implicated epigenetic silencing as a recurrent mechanism of PAX1 inactivation in endocrine tumors beyond cervical cancer.\",\n      \"evidence\": \"Bisulfite sequencing, ChIP for H3K9ac, 5-aza-dC treatment in rat parathyroid cells and human parathyroid adenoma tissues\",\n      \"pmids\": [\"34453169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of PAX1 re-expression on parathyroid cell growth was not assessed\",\n        \"Whether PAX1 silencing is a driver or passenger event in parathyroid tumorigenesis is unresolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of PAX1 interactions with its protein partners (SOX9, SET1B, Mox1), the genome-wide hierarchy of direct targets in thymic epithelium vs. sclerotome, and whether PAX1-based gene therapy can rescue SCID remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of PAX1 in complex with SOX9, SET1B, or DNA\",\n        \"Tissue-specific PAX1 cistrome comparing sclerotome, IVD, and thymic epithelium has not been generated\",\n        \"Functional rescue of PAX1-null SCID by thymus organoid transplant or gene correction is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 13, 15, 18]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [6, 13, 15, 16, 17, 18, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 6, 13, 17, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 8, 9, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 13, 15, 17, 18]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 10, 19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PAX9\",\n      \"SOX9\",\n      \"SET1B\",\n      \"HOXA3\",\n      \"MEOX1\",\n      \"MEOX2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}